For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist called Elecoglipron, which ...
People with an organ transplant who develop or have existing diabetes are more likely to die than those without diabetes, according to a comprehensive analysis of solid-organ transplant recipients presented at ENDO 2026, ...
Jun 13, 2026
0
5
A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases ...
Jun 13, 2026
0
6
Northwestern Medicine scientists have identified a safety concern associated with GLP-1 drugs. Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure ...
Jun 13, 2026
0
11
Some subgroups of children with precocious puberty—such as older girls with slowly progressing puberty—may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline ...
Jun 13, 2026
0
5
Researchers at the Monell Chemical Senses Center have found that common dietary sugars fructose and glucose, despite having the same number of calories, communicate with the brain through different gut–brain pathways, a difference ...
Jun 12, 2026
0
48
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter ...
Jun 12, 2026
0
7
The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.
Jun 12, 2026
0
5
A working professional who describes herself as "a tired mom of two" believes she's gaining the upper hand on a condition that's made her struggle with fatigue, weight gain, lethargy and hair loss.
Jun 12, 2026
0
8
For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study presented at the annual ...
Jun 11, 2026
0
7
